Placebo vs Nocebo Effect on Migraine Treatment

Placebo vs Nocebo Effect on Migraine Treatment

Category Placebo Effect Nocebo Effect
Definition An inactive treatment that leads to improvement in migraine due to positive patient expectations. A treatment (inactive or active) that leads to worsening of migraine or the presence of adverse effects due to negative patient expectations.
Incidence in clinical trials Up to 32.4% for acute treatments
Up to 30.4% for preventives
Up to 18.4% for acute treatments
Up to 47% for preventives
Enhancing Factors Positive doctor-patient relationship, parenteral route (especially surgery), specific drug mechanisms, branding/marketing, prior positive experiences. Psychiatric comorbidities, chronic migraine, prior treatment failures, generic medications, observation of side effects in others.
Psychological Basis Expectation of benefit, motivation, and reward circuits. Expectation of harm, fear, and avoidance circuits.
Physiological Basis Activation of descending pain pathways and dopamine reward circuits in the brain. Increased activity in brain regions processing fear, anxiety and pain sensations.
Clinical Importance Maximizing placebo can improve patient outcomes and treatment effectiveness. Minimizing nocebo can improve patient outcomes and treatment compliance.
Modifiability Can be enhanced through empathy, reassurance, positive framing by healthcare providers. Can be minimized through empathy, reassurance about side effects, careful adverse event reporting.
Back to blog
  • Migraine Attacks Independent of CGRP (cGMP-mediated migraine)

    Migraine Attacks Independent of CGRP (cGMP-medi...

    Cerebral Torque

    A randomized, double-blind, placebo-controlled study published in Cephalalgia investigated whether sildenafil (Viagra), a phosphodiesterase-5 (PDE-5) inhibitor that increases cGMP levels, could induce migraine attacks in individuals with migraine who were pre-treated with...

    Migraine Attacks Independent of CGRP (cGMP-medi...

    Cerebral Torque

    A randomized, double-blind, placebo-controlled study published in Cephalalgia investigated whether sildenafil (Viagra), a phosphodiesterase-5 (PDE-5) inhibitor that increases cGMP levels, could induce migraine attacks in individuals with migraine who were pre-treated with...

  • Migraine Aura vs TIA

    Migraine Aura vs TIA

    Cerebral Torque

    It can sometimes be difficult to distinguish between migraine aura and TIA, especially in cases of hemiplegic migraine, migraine with brainstem aura, or retinal migraine. Pay close attention to the...

    Migraine Aura vs TIA

    Cerebral Torque

    It can sometimes be difficult to distinguish between migraine aura and TIA, especially in cases of hemiplegic migraine, migraine with brainstem aura, or retinal migraine. Pay close attention to the...

  • The Migraine Brain Does NOT Like Routine: Do you want to win the battle or the war?

    The Migraine Brain Does NOT Like Routine: Do yo...

    Cerebral Torque

    Many in the migraine community have heard the common phrase "the migraine brain loves routine." However, a recent study suggests that this advice, while potentially helpful in the short-term, may...

    The Migraine Brain Does NOT Like Routine: Do yo...

    Cerebral Torque

    Many in the migraine community have heard the common phrase "the migraine brain loves routine." However, a recent study suggests that this advice, while potentially helpful in the short-term, may...

  • Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Migraine Treatment

    Cardiovascular Safety of Anti-CGRP Monoclonal A...

    Cerebral Torque

    The researchers discovered that 3.1% of participants experienced abnormal ECGs or cardiovascular adverse events. Among these, 1.6% encountered more severe complications, such as cerebellar stroke, spontaneous coronary artery dissection, or...

    Cardiovascular Safety of Anti-CGRP Monoclonal A...

    Cerebral Torque

    The researchers discovered that 3.1% of participants experienced abnormal ECGs or cardiovascular adverse events. Among these, 1.6% encountered more severe complications, such as cerebellar stroke, spontaneous coronary artery dissection, or...

1 of 4